337 The Discovery and Preclinical Characterization of CC-223, a Novel mTOR Kinase Inhibitor Under Clinical Investigation

Autor: Mortensen, D.S., Fultz, K.E., Hickman, M., Khambatta, G., Xu, W., Perrin-Ninkovic, S.M., Zhao, J., Narla, R.K., Raymon, H., Sankar, S.
Zdroj: In European Journal of Cancer November 2012 48 Supplement 6:103-103
Databáze: ScienceDirect